PEAR insider filings
Pear Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-04-12. Screen PEAR transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for PEAR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Pear Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-04-12 | 4 | 5AM Partners IV, LLC — 10% owner 5AM Ventures IV, L.P. — 10% owner 5AM Co-Investors IV, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner DIEKMAN JOHN D — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 12,836,489 @ $0.12 · Sale (S): 534,855 @ $0.12 · Sale (S): 3,172,769 @ $0.12 | EDGAR |
| 2023-02-17 | 4 | Brenner Erin K. — Chief Product Dev. Officer | Grant/award (A): 952,380 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | O'Brien Ronan — CCO, GC, & Secretary | Grant/award (A): 1,295,238 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Maricich Yuri — Chief Medical Officer | Grant/award (A): 1,333,333 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Strandberg Julia — Chief Commercial Officer | Grant/award (A): 1,409,523 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | McCann Corey — President and CEO, Director | Grant/award (A): 2,857,142 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Reddy Kirthiga — Director | Grant/award (A): 61,904 @ $0 | EDGAR |
| 2023-02-17 | 4 | Rajaraman Shivakumar — Director | Grant/award (A): 52,380 @ $0 | EDGAR |
| 2023-02-17 | 4 | Mango Paul — Director | Grant/award (A): 52,380 @ $0 | EDGAR |
| 2023-02-17 | 4 | Snow Ellen — VP, Chief Accounting Officer | Grant/award (A): 199,864 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Bauerlein Alison — Director | Grant/award (A): 71,428 @ $0 | EDGAR |
| 2023-02-17 | 4 | SCHLICHTING NANCY M — Director | Grant/award (A): 66,666 @ $0 | EDGAR |
| 2023-02-17 | 4 | Wicks Timothy A — Director | Grant/award (A): 52,380 @ $0 | EDGAR |
| 2023-02-17 | 4 | GUIFFRE CHRISTOPHERD T — CFO, COO, Treas., & Asst. Sec. | Grant/award (A): 2,285,714 (derivative) @ $0 | EDGAR |
| 2023-01-24 | 4 | O'Brien Ronan — GC, CCO & Secretary | Sale (S): 12,162 @ $1.13 | EDGAR |
| 2023-01-24 | 4 | Strandberg Julia — Chief Commercial Officer | Sale (S): 12,688 @ $1.13 | EDGAR |
| 2023-01-24 | 4 | Brenner Erin K. — Chief Product Dev. Officer | Sale (S): 8,690 @ $1.13 | EDGAR |
| 2023-01-24 | 4 | Maricich Yuri — Chief Medical Officer | Sale (S): 12,162 @ $1.13 | EDGAR |
| 2023-01-24 | 4 | McCann Corey — President and CEO, Director | Sale (S): 34,731 @ $1.13 | EDGAR |
| 2023-01-24 | 4 | Jeffery Katherine — Chief People Officer | Sale (S): 7,096 @ $1.13 | EDGAR |
| 2023-01-24 | 4 | Snow Ellen — Chief Accounting Officer | Sale (S): 8,027 @ $1.13 | EDGAR |
| 2023-01-24 | 4 | GUIFFRE CHRISTOPHERD T — CFO, COO, Treas., & Asst. Sec. | Sale (S): 19,540 @ $1.13 | EDGAR |
| 2023-01-18 | 4 | Brenner Erin K. — Chief Product Dev. Officer | Option exercise (M): 22,000 @ $0 · Option exercise (M): 22,000 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | Maricich Yuri — Chief Medical Officer | Option exercise (M): 30,800 @ $0 · Option exercise (M): 30,800 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | McCann Corey — President and CEO, Director | Option exercise (M): 88,000 @ $0 · Option exercise (M): 88,000 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | Strandberg Julia — Chief Commercial Officer | Option exercise (M): 33,000 @ $0 · Option exercise (M): 33,000 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | O'Brien Ronan — GC, CCO & Secretary | Option exercise (M): 30,800 @ $0 · Option exercise (M): 30,800 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | Jeffery Katherine — Chief People Officer | Option exercise (M): 15,400 @ $0 · Option exercise (M): 15,400 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | Snow Ellen — Chief Accounting Officer | Option exercise (M): 20,320 @ $0 · Option exercise (M): 20,320 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | GUIFFRE CHRISTOPHERD T — CFO, COO, Treas., & Asst. Sec. | Option exercise (M): 49,500 @ $0 · Option exercise (M): 49,500 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | LJ10 LLC — 10% owner KLP SPAC 1 LLC — 10% owner | Other (J): 430,000 @ $0 | EDGAR |
| 2022-12-09 | 4 | Brenner Erin K. — Chief Product Dev. Officer | Option exercise (M): 15,000 @ $1 · Option exercise (M): 15,000 (derivative) | EDGAR |
| 2022-11-15 | 4 | 5AM Partners IV, LLC — 10% owner 5AM Ventures IV, L.P. — 10% owner 5AM Co-Investors IV, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner DIEKMAN JOHN D — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 28,205 @ $3.19 · Sale (S): 1,175 @ $3.19 · Sale (S): 11,643 @ $2.79 · Sale (S): 485 @ $2.79 · Sale (S): 61,222 @ $2.52 · Sale (S): 2,551 @ $2.52 | EDGAR |
| 2022-11-02 | 4 | 5AM Partners IV, LLC — 10% owner 5AM Ventures IV, L.P. — 10% owner 5AM Co-Investors IV, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner DIEKMAN JOHN D — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 40,477 @ $2.78 · Sale (S): 1,687 @ $2.78 · Sale (S): 1,408 @ $2.80 · Sale (S): 59 @ $2.80 · Sale (S): 10,155 @ $2.72 · Sale (S): 423 @ $2.72 | EDGAR |
| 2022-09-16 | 4 | 5AM Partners IV, LLC — 10% owner 5AM Ventures IV, L.P. — 10% owner 5AM Co-Investors IV, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner DIEKMAN JOHN D — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 273,664 @ $1.94 · Sale (S): 11,403 @ $1.94 · Sale (S): 261,840 @ $1.81 · Sale (S): 10,910 @ $1.81 · Sale (S): 337 @ $1.75 · Sale (S): 14 @ $1.75 | EDGAR |
| 2022-09-08 | 4 | 5AM Partners IV, LLC — 10% owner 5AM Ventures IV, L.P. — 10% owner 5AM Co-Investors IV, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner DIEKMAN JOHN D — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 298,714 @ $2.36 · Sale (S): 12,446 @ $2.36 · Sale (S): 148,337 @ $1.92 · Sale (S): 6,181 @ $1.92 · Sale (S): 292,149 @ $1.81 · Sale (S): 12,173 @ $1.81 | EDGAR |
| 2022-08-18 | 4 | 5AM Partners IV, LLC — 10% owner 5AM Ventures IV, L.P. — 10% owner 5AM Co-Investors IV, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner DIEKMAN JOHN D — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 160,476 @ $1.78 · Sale (S): 6,686 @ $1.78 · Sale (S): 9,674 @ $1.71 · Sale (S): 403 @ $1.71 · Sale (S): 213,851 @ $1.55 · Sale (S): 8,910 @ $1.55 | EDGAR |
| 2022-06-16 | 4 | Reddy Kirthiga — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Mango Paul — Director | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Rajaraman Shivakumar — Director | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Bauerlein Alison — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | SCHLICHTING NANCY M — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Wicks Timothy A — Director | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Brenner Erin K. — Chief Product Dev. Officer | Option exercise (M): 15,000 @ $1 · Option exercise (M): 15,000 (derivative) | EDGAR |
| 2022-02-18 | 4 | Brenner Erin K. — Chief Product Dev. Officer | Grant/award (A): 52,520 (derivative) @ $0 · Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | Maricich Yuri — Chief Medical Officer | Grant/award (A): 73,528 (derivative) @ $0 · Grant/award (A): 93,333 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | Strandberg Julia — Chief Commercial Officer | Grant/award (A): 78,780 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | McCann Corey — President and CEO, Director | Grant/award (A): 210,080 (derivative) @ $0 · Grant/award (A): 266,667 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | Snow Ellen — Chief Accounting Officer | Grant/award (A): 61,576 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | GUIFFRE CHRISTOPHERD T — CFO, COO, Treas., & Asst. Sec. | Grant/award (A): 118,170 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Pear Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-04-10 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-04-07 | 8-K | 1.02 — Termination of a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-17 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2023-01-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-25 | 8-K | ? | EDGAR |
| 2022-06-24 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2022-06-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PEAR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs